Risks and limits of Abnehmspritze Alltag

Weight loss injections (GLP-1 receptor agonists like semaglutide) are prescription drugs approved for obesity and type 2 diabetes. In everyday life, they carry clear risks and limitations: common side effects include nausea, vomiting, diarrhea, and constipation, especially at the start. Rare but serious risks include pancreatitis, gallstones, and a potential for thyroid C-cell tumors. The injection does not replace long-term lifestyle changes – weight regain is common after discontinuation. Efficacy varies individually; not everyone responds equally. Costs are high and insurance coverage is strict. Importantly, these are not lifestyle products but medications requiring medical supervision. Without dietary changes and exercise, the effect is limited. Evidence comes from clinical trials, but long-term effects beyond a few years are not fully known. Consumers should not be misled by marketing claims and should seek professional medical advice.